Tatva Chintan Pharma
952.90
-6.70(-0.70%)
Market Cap₹2,244.70 Cr
PE Ratio392.93
IndustryChemicals
Company Performance:
1D-0.70%
1M+2.71%
6M+10.89%
1Y-16.06%
5Y-58.79%
View Company Insightsright
Latest news about Tatva Chintan Pharma
CRISIL Downgrades Tatva Chintan Pharma Chem's Ratings Amid Business Challenges Jun 18, 2025
CRISIL has downgraded Tatva Chintan Pharma Chem Ltd's ratings on bank facilities worth ₹245.00 crore. Long-term rating revised from A- (negative) to BBB+ (stable), and short-term rating from A2+ to A2. The downgrade is due to expected revenue decline to ₹385.00 crore and operating profit margin compression to 9.49% from 18.43%.
Tatva Chintan Pharma Chem Secures ₹29.95 Crore Export Order for Specialty Chemicals May 05, 2025
Tatva Chintan Pharma Chem Reports Q4 Profit Surge, Recommends Dividend May 05, 2025
Tatva Chintan Pharma Chem Reports Mixed Q4 Results, Recommends Dividend May 02, 2025